Dr. Blas Y. Betancourt, MD

Dr. Betancourt practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Betancourt's NPI, 1366856452, was assigned on June 17, 2014. Dr. Betancourt graduated from Instituto Superior de Ciencias Medicinas de Villa Clara in 1995. Dr. Betancourt holds Florida license ME141546.

Dr. Betancourt's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Betancourt's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Betancourt practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Betancourt's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Betancourt is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Betancourt's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Betancourt treats.

CMS data shows 588 Medicare services from Dr. Betancourt across 5 procedure codes in 2024, for 179 Medicare patients. Medicare paid $37,981 for them. Every service was in an office.

CMS counts 179 Medicare patients who saw Dr. Betancourt in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have arthritis, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Betancourt's median patient age at 68, with 72% women.

In 2024, Dr. Betancourt wrote 1,445 Medicare Part D claims for 236 patients. 80% of them were for generic drugs. CMS names the drug for 1,329 of them, across 30 drugs with 11 or more claims each, at $1,679,356 in total drug cost. In 2023, CMS named 1,355 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Betancourt for performance year 2024, reported through an alternative payment model (APM). Dr. Betancourt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Betancourt as offering telehealth.

Dmand AI links 10 papers to Dr. Betancourt, published from 2004 to 2019. 2005 was the busiest year, with 2. The most frequent topics are Streptokinase, Thrombolytic Therapy and Fibrinolytic Agents. Dr. Betancourt has published most often in Int Wound J. Dr. Betancourt's most frequent co-authors are James David Katz, MD and Alexander Sy, MD.

Dr. Betancourt graduated from Instituto Superior de Ciencias Medicinas de Villa Clara in 1995.

Dr. Betancourt is in network with 16 carriers, including Excellus BlueCross BlueShield, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.